Evidence map›Paper›PMID 32948812›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2021

Ascorbate-induced oxidative stress mediates TRP channel activation and cytotoxicity in human etoposide-sensitive and -resistant retinoblastoma cells.

Jakub Oronowicz, Jacqueline Reinhard, Peter Sol Reinach, Szymon Ludwiczak, Huan Luo, Marah Hussain Omar Ba Salem, Miriam Monika Kraemer, Heike Biebermann, Vinodh Kakkassery, Stefan Mergler

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Functional characterization of the αFrontiers in pharmacology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Jakub OronowiczKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Jacqueline ReinhardDepartment of Cell Morphology and Molecular Neurobiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.
Peter Sol ReinachSchool of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, PR China.ORCID 0000-0002-3494-4523
Szymon LudwiczakKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Huan LuoKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Marah Hussain Omar Ba SalemKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Miriam Monika KraemerDepartment of Cell Morphology and Molecular Neurobiology, Faculty of Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.
Heike BiebermannInstitut für Experimentelle Pädiatrische Endokrinologie, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Vinodh KakkasseryUniversität zu Lübeck, Klinik für Augenheilkunde - Universitätsklinikum Schleswig-Holstein (Campus Lübeck), Lübeck, Germany. vinodh.kakkassery@gmail.com.
Stefan MerglerKlinik für Augenheilkunde, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. stefan.mergler@charite.de.ORCID 0000-0001-8608-648X
Humboldt-Universität zu Berlin · DERuhr University Bochum · DEUniversitäres Kinderwunschzentrum Lübeck · DEWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are indications that pharmacological doses of ascorbate (Asc) used as an adjuvant improve the chemotherapeutic management of cancer. This favorable outcome stems from its cytotoxic effects due to prooxidative mechanisms. Since regulation of intracellular Ca

Indexed as

Antineoplastic Agents, PhytogenicAntioxidantsAscorbic AcidCalciumCell Line, TumorDrug Resistance, NeoplasmDrug Screening Assays, AntitumorEtoposideHumansOxidative StressRetinal NeoplasmsRetinoblastomaTransient Receptor Potential ChannelsAntineoplastic Agents, PhytogenicAntioxidantsAscorbic AcidCalciumEtoposideTransient Receptor Potential Channels

Identifiers

PMID32948812
PMCPMC7758186
OpenAlexW3087726176

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.